OA 05.06 Phase 2 Study of Lorlatinib in Patients with Advanced ALK + /ROS1 + Non-Small-Cell Lung Cancer

Title
OA 05.06 Phase 2 Study of Lorlatinib in Patients with Advanced ALK + /ROS1 + Non-Small-Cell Lung Cancer
Authors
Keywords
-
Journal
Journal of Thoracic Oncology
Volume 12, Issue 11, Pages S1756
Publisher
Elsevier BV
Online
2017-11-07
DOI
10.1016/j.jtho.2017.09.351

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search